How Not to Die

Home > Other > How Not to Die > Page 60
How Not to Die Page 60

by Michael Greger MD


  94. Taylor R. Pathogenesis of type 2 diabetes: tracing the reverse route from cure to cause. Diabetologia. 2008;51(10):1781–9.

  95. American Diabetes Association. Standards of medical care in diabetes—2015. Diabetes Care. 2015;38(suppl 1):S1–S93.

  96. Dunaief DM, Fuhrman J, Dunaief JL, et al. Glycemic and cardiovascular parameters improved in type 2 diabetes with the high nutrient density (HND) diet. Open Journal of Preventive Medicine. 2012;2(3):364–71.

  97. Lim EL, Hollingsworth KG, Aribisala BS, Chen MJ, Mathers JC, Taylor R. Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol. Diabetologia. 2011;54(10):2506–14.

  98. Steven S, Lim EL, Taylor R. Population response to information on reversibility of Type 2 diabetes. Diabet Med. 2013;30(4):e135–8.

  99. Dunaief DM, Fuhrman J, Dunaief JL, et al. Glycemic and cardiovascular parameters improved in type 2 diabetes with the high nutrient density (HND) diet. Open J Prev Med. 2012;2(3):364–71.

  100. Anderson JW, Ward K. High-carbohydrate, high-fibre diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr. 1979;32(11):2312–21.

  101. Anderson JW, Ward K. High-carbohydrate, high-fibre diets for insulin-treated men with diabetes mellitus. Am J Clin Nutr. 1979;32(11):2312–21.

  102. Callaghan BC, Cheng H, Stables CL, et al. Diabetic neuropathy: clinical manifestations and current treatments. Lancet Neurol. 2012;11(6):521–34.

  103. Said G. Diabetic neuropathy—a review. Nat Clin Pract Neurol. 2007;3(6):331–40.

  104. Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

  105. Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

  106. Rabinowitch IM. Effects of the high carbohydrate-low calorie diet upon carbohydrate tolerance in diabetes mellitus. Can Med Assoc J. 1935;33(2):136–44.

  107. Newborg B, Kempner W. Analysis of 177 cases of hypertensive vascular disease with papilledema; one hundred twenty-six patients treated with rice diet. Am J Med. 1955;19(1):33–47.

  108. Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

  109. Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

  110. Crane MG, Sample C. Regression of diabetic neuropathy with total vegetarian (vegan) diet. J Nutr Med. 1994;4(4):431–9.

  111. Crane MG, Zielinski R, Aloia R. Cis and trans fats in omnivores, lacto-ovo vegetarians and vegans. Am J Clin Nutr. 1988;48:920.

  112. Tesfaye S, Chaturvedi N, Eaton SEM, et al. Vascular risk factors and diabetic neuropathy. N Engl J Med. 2005;352(4):341–50.

  113. Newrick PG, Wilson AJ, Jakubowski J, et al. Sural nerve oxygen tension in diabetes. Br Med J (Clin Res Ed). 1986;293(6554):1053–4.

  114. McCarty MF. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002;58(6):476–86.

  115. Kempner W, Peschel RL, Schlayer C. Effect of rice diet on diabetes mellitus associated with vascular disease. Postgrad Med. 1958;24(4):359–71.

  116. McCarty MF. Favorable impact of a vegan diet with exercise on hemorheology: implications for control of diabetic neuropathy. Med Hypotheses. 2002;58(6):476–86.

  117. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.

  118. Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, S, Sørensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003;11(7):895–903.

  119. Bigaard J, Tjønneland A, Thomsen BL, Overvad K, Heitmann BL, S, Sørensen TI. Waist circumference, BMI, smoking, and mortality in middle-aged men and women. Obes Res. 2003;11(7):895–903.

  120. Leitzmann MF, Moore SC, Koster A, et al. Waist circumference as compared with body-mass index in predicting mortality from specific causes. PLoS One. 2011;6(4):e18582.

  121. Browning LM, Hsieh SD, Ashwell M. A systematic review of waist-to-height ratio as a screening tool for the prediction of cardiovascular disease and diabetes: 0·5 could be a suitable global boundary value. Nutr Res Rev. 2010;23(2):247–69.

  122. Centers for Disease Control and Prevention. National Diabetes Statistics Report: Estimates of Diabetes and Its Burden in the United States, 2014. Atlanta, GA: U.S. Department of Health and Human Services; 2014. http://www.cdc.gov/­diabetes/data/­statistics/­2014StatisticsReport.html. Updated October 24, 2014. Accessed March 6, 2015.

  123. Nathan DM, Davidson MB, Defronzo RA, et al. Impaired fasting glucose and impaired glucose tolerance: implications for care. Diabetes Care. 2007;30(3):753–9.

  124. Karve A, Hayward RA. Prevalence, diagnosis, and treatment of impaired fasting glucose and impaired glucose tolerance in nondiabetic U.S. adults. Diabetes Care. 2010;33(11):2355–9.

  125. Cardona-Morrell M, Rychetnik L, Morrell SL, Espinel PT, Bauman A. Reduction of diabetes risk in routine clinical practice: are physical activity and nutrition interventions feasible and are the outcomes from reference trials replicable? A systematic review and meta-analysis. BMC Public Health. 2010;10:653.

  126. Holman H. Chronic disease—the need for a new clinical education. JAMA. 2004;292(9):1057–9.

  127. Institute of Medicine. Crossing the Quality Chasm: A New Health System for the 21st Century. Washington, D.C.: The National Academies Press, 2001:213. http://www.iom.edu/­Reports/2001/­Crossing-the-Quality-Chasm-A-New-Health-System-for-the-21st-Century.aspx.

  7. How Not to Die from High Blood Pressure

  1. Lozano R, Naghavi M, Foreman K, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.

  2. Das P, Samarasekera U. The story of GBD 2010: a “super-human” effort. Lancet. 2012;380(9859):2067–70.

  3. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

  4. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

  5. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

  6. Bromfield S, Muntner P. High blood pressure: the leading global burden of disease risk factor and the need for worldwide prevention programs. Curr Hypertens Rep. 2013;15(3):134–6.

  7. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

  8. American Heart Association. Understanding Blood Pressure Readings. http://www.heart.org/­HEARTORG/Conditions/­HighBloodPressure/­AboutHighBloodPressure/­Understanding-Blood-Pressure-Readings_UCM_301764_Article.jsp. March 11, 2015. Accessed March 11, 2015.

  9. Go AS, Bauman MA, Coleman King SM, et al. An effective approach to high blood pressure control: a science advisory from the American Heart Association, the American College of Cardiology, and the Centers for Disease Control and Prevention. J Am Coll Cardiol. 2014;63(12):1230–8.

  10. Nwankwo T, Yoo
n SS, Burt V, Gu Q. Hypertension among adults in the United States: National Health and Nutrition Examination Survey, 2011–2012. NCHS Data Brief. 2013;(133):1–8.

  11. Walker AR, Walker BF. High high-density-lipoprotein cholesterol in African children and adults in a population free of coronary heart diseae. Br Med J. 1978;2(6148):1336–7.

  12. Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.

  13. Macmahon S, Neal B, Rodgers A. Hypertension—time to move on. Lancet. 2005;365(9464):1108–9.

  14. Law MR, Morris JK, Wald NJ. Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies. BMJ. 2009;338:b1665.

  15. Donnison CP. Blood pressure in the African native. Lancet. 1929;213(5497):6–7.

  16. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

  17. Lim SS, Vos T, Flaxman AD, et al. A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990–2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2224–60.

  18. Karppanen H, Mervaala E. Sodium intake and hypertension. Prog Cardiovasc Dis. 2006;49(2):59–75.

  19. Delahaye F. Should we eat less salt? Arch Cardiovasc Dis. 2013;106(5): 324–32.

  20. Jenkins DJ, Kendall CW. The garden of Eden: plant-based diets, the genetic drive to store fat and conserve cholesterol, and implications for epidemiology in the 21st century. Epidemiology. 2006;17(2):128–30.

  21. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.

  22. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.

  23. Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.

  24. Whelton PK, Appel LJ, Sacco RL, et al. Sodium, blood pressure, and cardiovascular disease: further evidence supporting the American Heart Association sodium reduction recommendations. Circulation. 2012;126(24):2880–9.

  25. Centers for Disease Control and Prevention. Sodium intake among adults - United States, 2005–2006. MMWR Morb Mortal Wkly Rep. 2010;59(24):746–9.

  26. Beaglehole R, Bonita R, Horton R, et al. Priority actions for the noncommunicable disease crisis. Lancet. 2011;377(9775):1438–47.

  27. Law MR, Frost CD, Wald NJ. By how much does dietary salt reduction lower blood pressure? III—Analysis of data from trials of salt reduction. BMJ. 1991;302(6780):819–24.

  28. Bibbins-Domingo K, Chertow GM, Coxson PG, et al. Projected effect of dietary salt reductions on future cardiovascular disease. N Engl J Med. 2010 Feb 18;362(7):590–9.

  29. MacGregor GA, Markandu ND, Best FE, et al. Double-blind randomised crossover trial of moderate sodium restriction in essential hypertension. Lancet. 1982;1(8268):351–5.

  30. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674):1244–7.

  31. MacGregor GA, Markandu ND, Sagnella GA, Singer DR, Cappuccio FP. Double-blind study of three sodium intakes and long-term effects of sodium restriction in essential hypertension. Lancet. 1989;2(8674):1244–7.

  32. Rudelt A, French S, Harnack L. Fourteen-year trends in sodium content of menu offerings at eight leading fast-food restaurants in the USA. Public Health Nutr. 2014;17(8):1682–8.

  33. Suckling RJ, He FJ, Markandu ND, MacGregor GA. Dietary salt influences postprandial plasma sodium concentration and systolic blood pressure. Kidney Int. 2012;81(4):407–11.

  34. He FJ, Li J, MacGregor GA. Effect of longer term modest salt reduction on blood pressure: Cochrane systematic review and meta-analysis of randomised trials. BMJ. 2013;346:f1325.

  35. Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.

  36. Oliver WJ, Cohen EL, Neel JV. Blood pressure, sodium intake, and sodium related hormones in the Yanomamo Indians, a “no-salt” culture. Circulation. 1975;52(1):146–51.

  37. Mancilha-Carvalho J de J, de Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80(3):289–300.

  38. Celermajer DS, Neal B. Excessive sodium intake and cardiovascular disease: a-salting our vessels. J Am Coll Cardiol. 2013;61(3):344–5.

  39. Mancilha-Carvalho J de J, de Souza e Silva NA. The Yanomami Indians in the INTERSALT Study. Arq Bras Cardiol. 2003;80(3):289–300.

  40. Mancilha-Carvalho J de J, Crews DE. Lipid profiles of Yanomamo Indians of Brazil. Prev Med. 1990;19(1):66–75.

  41. Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.

  42. Klemmer P, Grim CE, Luft FC. Who and what drove Walter Kempner? The rice diet revisited. Hypertension. 2014;64(4):684–8.

  43. Kempner W. Treatment of heart and kidney disease and of hypertensive and arteriosclerotic vascular disease with the rice diet. Ann Intern Med. 1949;31(5):821–56.

  44. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.

  45. Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93(3):500–5.

  46. DuPont JJ, Greaney JL, Wenner MM, et al. High dietary sodium intake impairs endothelium-dependent dilation in healthy salt-resistant humans. J Hypertens. 2013;31(3):530–6.

  47. Dickinson KM, Clifton PM, Keogh JB. Endothelial function is impaired after a high-salt meal in healthy subjects. Am J Clin Nutr. 2011;93(3):500–5.

  48. Greaney JL, DuPont JJ, Lennon-Edwards SL, Sanders PW, Edwards DG, Farquhar WB. Dietary sodium loading impairs microvascular function independent of blood pressure in humans: role of oxidative stress. J Physiol (Lond). 2012;590(Pt 21):5519–28.

  49. Jablonski KL, Racine ML, Geolfos CJ, et al. Dietary sodium restriction reverses vascular endothelial dysfunction in middle-aged/older adults with moderately elevated systolic blood pressure. J Am Coll Cardiol. 2013;61(3):335–43.

  50. McCord JM. Analysis of superoxide dismutase activity. Curr Protoc Toxicol. 1999;Chapter 7:Unit 7.3.

  51. Dickinson KM, Clifton PM, Burrell LM, Barrett PHR, Keogh JB. Postprandial effects of a high salt meal on serum sodium, arterial stiffness, markers of nitric oxide production and markers of endothelial function. Atherosclerosis. 2014;232(1):211–6.

  52. Huang Ti Nei Ching Su Wua [The Yellow Emperor’s Classic of Internal Medicine] (Veith I, Trans.) Oakland, CA: University of California Press; 1972:141.

  53. Hanneman RL, Satin M. Comments to the Dietary Guidelines Committee on behalf of the Salt Institute. Comment ID: 000447. April 23, 2009.

  54. Vital signs: food categories contributing the most to sodium consumption - United States, 2007–2008. MMWR Morb Mortal Wkly Rep. 2012;61(5):92–8.

  55. Miller GD. Comments to the Dietary Guidelines Committee on behalf of the National Dairy Council, July 27, 2009.

  56. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.

  57. MacGregor G, de Wardener HE. Salt, blood pressure and health. Int J Epidemiol. 2002;31(2):320–7.

  58. Appel LJ, Anderson CAM. Compelling evidence for public health action to reduce salt intake. N Engl J Med. 2010;362(7):650–2.

  59. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood
pressure. Am J Cardiol. 2001;88(11):1338–46.

  60. Buying this chicken? Consum Rep. June 2008;7.

  61. Drewnowski A, Rehm CD. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013;5(6):1840–55.

  62. U.S. Department of Agriculture, Agricultural Research Service. 2014. USDA National Nutrient Database for Standard Reference, Release 27. Pizza Hut 14” pepperoni pizza, pan crust. http://ndb.nal.usda.gov/­ndb/foods/­show/6800. Accessed March 22, 2015.

  63. Drewnowski A, Rehm CD. Sodium intakes of US children and adults from foods and beverages by location of origin and by specific food source. Nutrients. 2013;5(6):1840–55.

  64. Blais CA, Pangborn RM, Borhani NO, Ferrell MF, Prineas RJ, Laing B. Effect of dietary sodium restriction on taste responses to sodium chloride: a longitudinal study. Am J Clin Nutr. 1986;44(2):232–43.

  65. Tucker RM, Mattes RD. Are free fatty acids effective taste stimuli in humans? Presented at the symposium “The Taste for Fat: New Discoveries on the Role of Fat in Sensory Perception, Metabolism, Sensory Pleasure and Beyond” held at the Institute of Food Technologists 2011 Annual Meeting, New Orleans, LA, June 12, 2011. J Food Sci. 2012;77(3):S148–51.

  66. Grieve FG, Vander Weg MW. Desire to eat high- and low-fat foods following a low-fat dietary intervention. J Nutr Educ Behav. 2003;35(2): 98–102.

  67. Stewart JE, Newman LP, Keast RS. Oral sensitivity to oleic acid is associated with fat intake and body mass index. Clin Nutr. 2011;30(6):838–44.

  68. Stewart JE, Keast RS. Recent fat intake modulates fat taste sensitivity in lean and overweight subjects. Int J Obes (Lond). 2012;36(6):834–42.

  69. Roberts WC. High salt intake, its origins, its economic impact, and its effect on blood pressure. Am J Cardiol. 2001;88(11):1338–46.

  70. Newson RS, Elmadfa I, Biro G, et al. Barriers for progress in salt reduction in the general population. An international study. Appetite. 2013;71:22–31.

  71. Cappuccio FP, Capewell S, Lincoln P, McPherson K. Policy options to reduce population salt intake. BMJ. 2011;343:d4995.

 

‹ Prev